Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria

PHASE2CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

April 10, 2018

Primary Completion Date

May 7, 2019

Study Completion Date

June 4, 2019

Conditions
Diabetic Kidney Disease
Interventions
DRUG

TMX-049

A certain dose of TMX-049 to be taken orally, once daily

DRUG

Placebo

Matching placebo to be taken orally, once daily

Trial Locations (55)

12206

Albany Medical College, Division of Community Endocinology, Albany

19446

Detweiler Family Medicine & Associates, PC, Lansdale

20110

Manassas Clinical Research Center, Manassas

20852

Biolab Research LLC, Rockville

27103

Brookview Hills Research Associates, LLC, Winston-Salem

27203

Randolph Health Internal Medicine, Asheboro

28401

PMG Research of Wilmington, LLC, Wilmington

28557

Carteret Medical Group, Morehead City

30901

Nephrology Associates, PC, Augusta

30909

Southeastern Clinical Research Institute, Augusta

33014

San Marcus Research Clinic, Inc., Miami Lakes

33015

Leon Medical Research, Miami

33026

Pines Care Research Center, Pembroke Pines

33952

Hanson Clinical Research Center, Port Charlotte

34761

Endocrine Associates of Florida, P.A., Ocoee

37411

University Diabetes & Endocrine Consultants, Chattanooga

37923

Knoxville Kidney Center, PLLC, Knoxville

42003

Four Rivers Clincial Research, Paducah

46011

Community Clinical Research Center, Anderson

Community Hospital of Anderson and Madison County, Inc., Anderson

48504

Aa Mrc Llc, Flint

48532

Elite Research Center LLC, Flint

Endocrine Consultants of Mid Michigan, Flint

50265

Iowa Kidney Physicians, Des Moines

Iowa Diabetes and Endocrinology Research Center, West Des Moines

60124

Associate in Endocrinology, Elgin

66502

My Kidney Center, LLC., Manhattan

66606

Cotton O'Neil Clinical Research Center, Topeka

70809

Ochsner Clinic Foundation, Baton Rouge, Baton Rouge

73111

Synexus Clinical Research US, Inc. Centennial Health, PC, Oklahoma City

75243

Texas Health Physicians Group, Dallas

76116

The Medical Group of Texas, Fort Worth

76164

Rockwood Medical Clinic, Fort Worth

77004

Endocrine Associates, Houston

77040

Juno Research, LLC, Houston

77079

The Endocrine Center, Houston

77099

Pioneer Research Solutions INC, Houston

77429

Houston Nephrology Research, Houston

77478

Carl R. Meisner Medical Clinic, PLLC, Sugar Land

78212

Clinical Advancement Center, PLLC, San Antonio

78249

BFHC Research, San Antonio

83646

Solaris Clinical Research, Llc, Meridian

84108

University of Utah School of Medicine, Salt Lake City

85210

Aventiv Research Inc., Mesa

86001

AKDHC Medical Research Services, LLC, Flagstaff

90717

Torrance Clinical Research Institute, Inc., Lomita

91325

Valley Clinical Trials, Inc., Northridge

91723

California Kidney Specialists, Covina

91773

California Kidney Specialists, San Dimas

North America Research Institute, San Dimas

91801

Comprehensive Research Institute, Alhambra

92262

Desert Oasis Healthcare Medical Group, Palm Springs

92868

Diabetes Associates Medical Group, Orange

96814

East-West Medical Research Institute, Honolulu

03801

Seacost Kidney & Hypertension Specialists, Portsmouth

All Listed Sponsors
lead

Teijin America, Inc.

INDUSTRY

NCT03449199 - Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria | Biotech Hunter | Biotech Hunter